• Markets
    • icon
  • Companies
EHE · ASX

Estia Health Ltd. (ASX:EHE)

AU$3.08

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
Recent Earnings upgrade Near Support Near Resistance Near 52 Week High HALO Small +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EHE Overview

EHE Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About EHE

Website

Estia Health Ltd.

Telephone

61.2.9265.7900

Address

Level 9 227 Elizabeth Street Sydney, New South Wales (NSW) 2000

Description

Estia Health Ltd. engages in the provision of residential aged care homes. It offers health and wellbeing services to its residents such as gardening, reading, movies, music, parties, cultural celebrations, art and craft sessions, and daytrips; dining and nutrition; and clinical care programs. The company was founded by Peter Arvanitis in 2005 and is headquartered in Sydney, Australia.

EHE Price Chart

Key Stats

Market Cap

AU$797.76M

PE

25.40

EV/EBITDA

9.1

Dividends Overview

DIV Yield

3.4%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.93 - 3.13

Trade Value (12mth)

AU$735,245.00

1 week

0.98%

1 month

0.65%

YTD

45.28%

1 year

50.24%

All time high

7.41582

Key Fundamentals

EPS 3 yr Growth

-70.700%

EBITDA Margin

16.00%

Operating Cashflow

$187m

Free Cash Flow Return

28.30%

ROIC

-5.10%

Interest Coverage

2.40

Quick Ratio

0.00

Other Data

Shares on Issue (Fully Dilluted)

258m

HALO Sector

Healthcare

Next Company Report Date

19-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EHE Announcements

Latest Announcements

Date Announcements

31 May 22

Appendix 3C

×

Appendix 3C

31 March 22

Appendix 3C

×

Appendix 3C

31 January 22

Bed Licence Accounting Implications and Trading Update

×

Bed Licence Accounting Implications and Trading Update

30 September 22

Annual Report 2022

×

Annual Report 2022

30 September 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 September 22

Notice of Annual General Meeting & Voting/Proxy Form

×

Notice of Annual General Meeting & Voting/Proxy Form

30 September 22

Online Meeting Guide

×

Online Meeting Guide

30 May 22

Appendix 3C

×

Appendix 3C

30 March 22

Appendix 3C

×

Appendix 3C

29 September 23

Change in substantial holding

×

Change in substantial holding

29 March 22

Appendix 3C

×

Appendix 3C

29 July 22

Final Director's Interest Notice

×

Final Director's Interest Notice

29 August 16

EHE FY16 Presentation

×

EHE FY16 Presentation

28 September 17

Estia Health Limited 2017 Annual Meeting Date

×

Estia Health Limited 2017 Annual Meeting Date

28 November 23

Foreign Investment Review Board Approval

×

Foreign Investment Review Board Approval

28 November 23

Change in substantial holding

×

Change in substantial holding

28 March 22

Appendix 3C

×

Appendix 3C

28 July 23

Update on engagement with Bain Capital

×

Update on engagement with Bain Capital

28 February 22

Appendix 3C

×

Appendix 3C

28 August 23

Ceasing to be a substantial holder from ARG

×

Ceasing to be a substantial holder from ARG

27 May 22

Appendix 3C

×

Appendix 3C

27 June 22

Appendix 3C

×

Appendix 3C

27 July 23

FY23 Full Year Results Date

×

FY23 Full Year Results Date

27 February 23

Change of Director's Interest Notice - Dr Gary Weiss

×

Change of Director's Interest Notice - Dr Gary Weiss

26 October 22

Jarden Conference Presentation

×

Jarden Conference Presentation

26 October 18

Annual Report

×

Annual Report

26 October 18

Notice of Annual General Meeting & Proxy Form

×

Notice of Annual General Meeting & Proxy Form

26 May 22

Appendix 3C

×

Appendix 3C

26 July 22

Change in substantial holding from PPT

×

Change in substantial holding from PPT

EHE Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.02 -0.20 -0.13 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.02 -0.20 -0.13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 104.8 -1,039.3 34.7 Lock Lock Lock
     PE X Lock Lock Lock Lock 77.2 73.4 25.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 8.5 7.2 9.1 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.13 0.09 0.39 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.03 0.04 0.45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -40.7 -34.5 362.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.3 2.3 15.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.02 0.02 0.16 Lock Lock Lock
     Growth % Lock Lock Lock Lock -57.4 2.2 568.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.5 1.8 3.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 107 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 2.35 2.10 1.94 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -1.12 -1.18 -1.16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -5.4 1.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 264 261 258 Lock Lock Lock
Basic m Lock Lock Lock Lock 261 261 258 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 646 671 754 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.5 3.8 12.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 31 36 50 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 106 49 54 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.6 -53.8 10.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 16.4 7.3 7.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 84 93 93 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 118 119 121 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.5 0.2 2.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 18.3 17.7 16.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 43 105 126 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 76 13 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.6 -82.6 -137.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 11.7 2.0 -0.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 9 -74 -43 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 3 -21 -9 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 6 -52 -34 Lock Lock Lock
     Growth % Lock Lock Lock Lock 104.8 -1,034.2 35.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.9 -7.8 -4.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 55 56 187 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 48 33 62 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -33 -30 -138 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -20 -39 -43 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 8 24 126 Lock Lock Lock
     Growth % Lock Lock Lock Lock -84.0 188.9 429.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.0 0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 25 26 14 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 33 20 26 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 1,907 1,838 1,915 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 175 157 127 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 146 141 105 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1,294 1,296 1,415 Lock Lock Lock
Equity $m Lock Lock Lock Lock 613 542 501 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 788 699 628 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.3 -11.3 -10.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 0.3 -2.8 -1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 0.9 -9.7 -6.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 9.5 1.8 -0.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 0.7 -7.0 -5.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 7.0 7.5 28.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 2.4 2.6 2.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 1.2 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 23.7 25.9 20.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.1 0.1 0.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.1 0.0 0.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 64.3 39.3 43.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 5.7 5.5 16.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 90.7 45.7 30.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 180.9 263.9 202.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.1 2.2 2.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.4 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.4 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 1.3 -11.0 -5.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.4 -4.0 -2.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 34.1 N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 0.3 -2.8 -1.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 3.1 3.4 3.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 0.9 -9.7 -6.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock -7.5 111.7 219.6 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -0.1 -10.8 -14.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 2.0 1.4 1.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 4.0 8.0 11.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 6.0 9.4 13.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 9.3 8.3 7.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -3.2 1.1 6.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

3.4%

Franking Level

100%

DPSg

568.09%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EHE Shortsell

Frequently Asked Questions

The current share price of Estia Health Ltd. (EHE:ASX) is AU$3.08.
The 52-week high share price for Estia Health Ltd. (EHE:ASX) is AU$3.13.
The 52-week low share price for Estia Health Ltd. (EHE:ASX)? is AU$1.93.
The current TTM dividend payout for Estia Health Ltd. (EHE:ASX) is 3.40.
The last dividend payment of Estia Health Ltd. (EHE:ASX) is AU$0.12.
Estia Health Ltd. (EHE:ASX) has a franking level of 100%.
Estia Health Ltd. (EHE:ASX) is classified in the Healthcare.
The current P/E ratio for Estia Health Ltd. (EHE:ASX) is 25.40.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.